- Home
- SVRA vs TWFG Comparison
SVRA vs TWFG Comparison
Compare SVRA & TWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- TWFG
- Stock Information
- Founded
- SVRA 2007
- TWFG 2001
- Country
- SVRA United States
- TWFG United States
- Employees
- SVRA N/A
- TWFG N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- TWFG
- Sector
- SVRA Health Care
- TWFG
- Exchange
- SVRA Nasdaq
- TWFG NYSE
- Market Cap
- SVRA 528.3M
- TWFG 530.3M
- IPO Year
- SVRA N/A
- TWFG 2024
- Fundamental
- Price
- SVRA $2.21
- TWFG $35.37
- Analyst Decision
- SVRA Buy
- TWFG Buy
- Analyst Count
- SVRA 5
- TWFG 8
- Target Price
- SVRA $5.60
- TWFG $33.71
- AVG Volume (30 Days)
- SVRA 1.2M
- TWFG 120.7K
- Earning Date
- SVRA 08-11-2025
- TWFG 08-26-2025
- Dividend Yield
- SVRA N/A
- TWFG N/A
- EPS Growth
- SVRA N/A
- TWFG N/A
- EPS
- SVRA N/A
- TWFG N/A
- Revenue
- SVRA N/A
- TWFG $211,440,000.00
- Revenue This Year
- SVRA N/A
- TWFG $23.90
- Revenue Next Year
- SVRA N/A
- TWFG $22.60
- P/E Ratio
- SVRA N/A
- TWFG N/A
- Revenue Growth
- SVRA N/A
- TWFG 18.57
- 52 Week Low
- SVRA $1.89
- TWFG $21.31
- 52 Week High
- SVRA $5.11
- TWFG $36.85
- Technical
- Relative Strength Index (RSI)
- SVRA 41.30
- TWFG N/A
- Support Level
- SVRA $1.98
- TWFG N/A
- Resistance Level
- SVRA $2.29
- TWFG N/A
- Average True Range (ATR)
- SVRA 0.14
- TWFG 0.00
- MACD
- SVRA 0.02
- TWFG 0.00
- Stochastic Oscillator
- SVRA 42.19
- TWFG 0.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.